Nordea Investment Management Ab Gilead Sciences, Inc. Transaction History

Nordea Investment Management Ab

$82.6 Billion
Q2 2024

A detailed history of Nordea Investment Management Ab transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Nordea Investment Management Ab holds 987,217 shares of GILD stock, worth $87 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

987,217

Previous 1,035,925 4.7%

Holding current value

$87 Million

Previous $75.9 Million 10.74%

% of portfolio

0.08%

Previous 0.09%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$63.15 - $72.88 $3.08 Million - $3.55 Million	-48,708 Reduced 4.7%	987,217 $67.7 Million
Q1 2024 May 02, 2024	SELL	$71.58 - $87.29 $6.29 Million - $7.67 Million	-87,815 Reduced 7.81%	1,035,925 $75.9 Million
Q4 2023 Jan 10, 2024	BUY	$73.27 - $83.09 $28.3 Million - $32 Million	385,630 Added 52.25%	1,123,740 $91 Million
Q3 2023 Nov 13, 2023	SELL	$73.94 - $80.67 $961,441 - $1.05 Million	-13,003 Reduced 1.73%	738,110 $55.3 Million
Q2 2023 Jul 07, 2023	SELL	$76.01 - $86.7 $3.45 Million - $3.93 Million	-45,330 Reduced 5.69%	751,113 $57.9 Million
Q1 2023 Apr 19, 2023	SELL	$77.31 - $88.08 $1.3 Million - $1.48 Million	-16,785 Reduced 2.06%	796,443 $66.1 Million
Q4 2022 Feb 08, 2023	SELL	$62.32 - $89.47 $4.8 Million - $6.89 Million	-76,969 Reduced 8.65%	813,228 $69.8 Million
Q3 2022 Oct 19, 2022	SELL	$59.54 - $68.01 $6.51 Million - $7.43 Million	-109,308 Reduced 10.94%	890,197 $56.2 Million
Q2 2022 Aug 09, 2022	SELL	$57.72 - $65.01 $5.68 Million - $6.39 Million	-98,320 Reduced 8.96%	999,505 $61.6 Million
Q1 2022 Apr 11, 2022	SELL	$57.92 - $72.58 $2.38 Million - $2.98 Million	-41,082 Reduced 3.61%	1,097,825 $65.7 Million
Q4 2021 Jan 20, 2022	BUY	$64.88 - $73.64 $4.14 Million - $4.7 Million	63,845 Added 5.94%	1,138,907 $83.4 Million
Q3 2021 Nov 01, 2021	SELL	$67.69 - $73.03 $72.8 Million - $78.5 Million	-1,075,062 Reduced 50.0%	1,075,062 $76.4 Million
Q3 2021 Nov 01, 2021	BUY	$67.69 - $73.03 $72.8 Million - $78.6 Million	1,076,074 Added 100.19%	2,150,124 $150 Million
Q2 2021 Jul 16, 2021	BUY	$63.47 - $69.35 $74,006 - $80,862	1,166 Added 0.11%	1,074,050 $74 Million
Q1 2021 May 17, 2021	SELL	$60.0 - $68.46 $12.2 Million - $13.9 Million	-203,610 Reduced 15.95%	1,072,884 $69.4 Million
Q4 2020 Feb 12, 2021	SELL	$56.65 - $64.55 $838,816 - $955,791	-14,807 Reduced 1.15%	1,276,494 $74.4 Million
Q3 2020 Nov 09, 2020	SELL	$62.1 - $78.08 $28.3 Million - $35.6 Million	-455,341 Reduced 26.07%	1,291,301 $80.7 Million
Q2 2020 Aug 13, 2020	BUY	$72.34 - $84.0 $64.2 Million - $74.6 Million	887,810 Added 103.37%	1,746,642 $134 Million
Q1 2020 May 15, 2020	SELL	$62.63 - $80.22 $1.86 Million - $2.38 Million	-29,666 Reduced 3.34%	858,832 $64.2 Million
Q4 2019 Feb 11, 2020	SELL	$61.62 - $67.78 $587,669 - $646,417	-9,537 Reduced 1.06%	888,498 $57.3 Million
Q3 2019 Nov 13, 2019	SELL	$62.51 - $69.0 $293,359 - $323,817	-4,693 Reduced 0.52%	898,035 $56.9 Million
Q2 2019 Aug 14, 2019	SELL	$61.87 - $69.38 $11.9 Million - $13.4 Million	-193,043 Reduced 17.62%	902,728 $61 Million
Q1 2019 May 20, 2019	BUY	$62.53 - $70.05 $4.35 Million - $4.88 Million	69,597 Added 6.78%	1,095,771 $71.2 Million
Q4 2018 Feb 14, 2019	BUY	$60.54 - $79.0 $7.7 Million - $10 Million	127,140 Added 14.14%	1,026,174 $64.2 Million
Q3 2018 Nov 14, 2018	SELL	$71.28 - $78.92 $1.36 Million - $1.5 Million	-19,018 Reduced 2.07%	899,034 $69.4 Million
Q2 2018 Aug 13, 2018	SELL	$64.88 - $75.68 $207,745 - $242,327	-3,202 Reduced 0.35%	918,052 $65 Million
Q1 2018 May 14, 2018	SELL	$72.84 - $88.8 $1.07 Million - $1.3 Million	-14,628 Reduced 1.56%	921,254 $69.5 Million
Q4 2017 Feb 12, 2018	SELL	$71.15 - $83.52 $18.5 Million - $21.7 Million	-259,583 Reduced 21.71%	935,882 $67 Million
Q3 2017 Nov 09, 2017	BUY	$72.11 - $85.47 $86.2 Million - $102 Million	1,195,465	1,195,465 $96.9 Million

Others Institutions Holding GILD

# of Institutions

1,893

Shares Held

1.02B

Call Options Held

12M

Put Options Held

8.96M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nordea Investment Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on Nordea Investment Management Ab with notifications on news.

Account

Nordea Investment Management Ab Gilead Sciences, Inc. Transaction History